Dose escalation of ripretinib can lead to response in advanced gastrointestinal stromal tumor patients refractory to the standard dose: a report of two cases
2021
Keywords:
-
Correction
-
Source
-
Cite
-
Save
15
References
1
Citations
NaN
KQI